Cassidy Parshall

Oct 17, 2023 | citizen.org | Peter Maybarduk |Brook K Baker |Cassidy Parshall

Introduction Today, the United States International Trade Commission (USITC) is releasing the results of its fact-finding investigation on access to COVID-19 diagnostics and therapeutics and flexibilities under the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement.[1] The United States Trade Representative called for the investigation at the end of 2022, and requested information on topics ranging from supply chain and distribution to compulsory licensing and access to...